Isoprenoids, or terpenoids, have wide applications in
food, feed,
pharmaceutical, and cosmetic industries. Nerolidol, an acyclic C15
isoprenoid, is widely used in cosmetics, food, and personal care products.
Current supply of nerolidol is mainly from plant extraction that is
inefficient, costly, and of inconsistent quality. Here, we screened
various nerolidol synthases from bacteria, fungi, and plants and found
that the strawberry nerolidol synthase was most active in Escherichia coli. Through systematic optimization
of the biosynthetic pathways, carbon sources, inducer, and genome
editing, we constructed a series of deletion strains (single mutants
ΔldhA, ΔpoxB, ΔpflB, and ΔtnaA; double mutants ΔadhE-ΔldhA; and triple mutants and
beyond ΔadhE-ΔldhA-ΔpflB and ΔadhE-ΔldhA-ΔackA-pta) that produced
high yields of 100% trans-nerolidol. In flasks, the
highest nerolidol titers were 1.8 and 3.3 g/L in glucose-only and
glucose–lactose–glycerol media, respectively. The highest
yield reached 26.2% (g/g), >90% of the theoretic yield. In two-phase
extractive fed-batch fermentation, our strain produced ∼16
g/L nerolidol within 4 days with about 9% carbon yield (g/g). In a
single-phase fed-batch fermentation, the strain produced >6.8 g/L
nerolidol in 3 days. To the best of our knowledge, our titers and
productivity are the highest in the literature, paving the way for
future commercialization and inspiring biosynthesis of other isoprenoids.